« Forget Instant Replay in the NFL: LASIK the Refs! | Main | The Aging Eye and Lens Dysfunction »

September 30, 2008

EyeCare 20/20 Dons Denim For A Cause

October 3 won't be any ordinary casual Friday at EyeCare 20/20. The denim worn on this day will not only be worn for comfort, but it will also make a powerful statement for an important cause. As Lee National Denim Day moves into its thirteenth year, EyeCare 20/20 is gearing up for its third year in this grassroots program which has raised more than $70 million for breast cancer research.

Employees at EyeCare 20/20 are encouraged to wear denim in exchange for a $5 donation to the Woman's Cancer Programs of the Entertainment Industry Foundation (EIF). Funds raised support some of the most promising treatment and early detection research in the country, as well as the grassroots advocacy work of the National Breast Cancer Coalition.

"We're always looking for interesting ways for our employees to get involved in fundraising activities, " said Cary M. Silverman, M.D., Medical Director of EyeCare 20/20. "Lee National Denim Day is easy and fun to do. Everyone gets to wear jeans to work in exchange for a $5 donation and the money helps fight breast cancer, a cause that is very important to many of our employees."

"Every year we are inspired by the number of people at thousands of organizations across the nation who join us in wearing denim on Lee National Denim Day, " said Liz Cahill, Vice President of Marketing Communications for Lee Jeans. "The money we're raising will be used to advance some of the most promising breast cancer research in the industry and we can't thank them enough."

For more information on Lee National Denim Day or to make a donation, visit www.denimday.com.

Ribbon_only

TrackBack

TrackBack URL for this entry:
https://www.typepad.com/services/trackback/6a00e55215d36f8834010535034a44970c

Listed below are links to weblogs that reference EyeCare 20/20 Dons Denim For A Cause:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.